GuruFocus.com
NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
➖
AI Sentiment
Neutral
4/10
- Home
- NMTC
as of 02-20-2026 3:32pm EST
$0.70
$0.01
-1.67%
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | 41.0M | IPO Year: | 2010 |
| Target Price: | $2.23 | AVG Volume (30 days): | 242.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | 80.43 |
| 52 Week Low/High: | $0.40 - $1.18 | Next Earning Date: | 05-18-2026 |
| Revenue: | $9,097,692 | Revenue Growth: | 163.47% |
| Revenue Growth (this year): | -5.09% | Revenue Growth (next year): | 32.08% |
| P/E Ratio: | -23.87 | Index: | N/A |
| Free Cash Flow: | -2919014.0 | FCF Growth: | N/A |
AI-Powered NMTC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 71.79%
71.79%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest NeuroOne Medical Technologies Corporation News
NMTC Breaking Stock News: Dive into NMTC Ticker-Specific Updates for Smart Investing
NewMediaWire
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
📈
AI Sentiment
Highly Positive
8/10
Compare NMTC vs Leading Stocks
See how NMTC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NMTC NeuroOne Medical Technologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.